% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Galldiks:865194,
author = {Galldiks, Norbert and Verger, Antoine and Zaragori,
Timothée and Unterrainer, Marcus and Suchorska, Bogdana and
Lohman, Philipp and Tonn, Jörg C and Langen, Karl-Josef and
Albert, Nathalie L},
title = {{C}omment on “{H}ypometabolic gliomas on {FET}-{PET} -
{I}s there an inverted {U}-curve for survival?”, {K}amson
2019, {N}euro-{O}ncology},
journal = {Neuro-Oncology},
volume = {21},
number = {12},
issn = {1523-5866},
address = {Oxford},
publisher = {Oxford Univ. Press},
reportid = {FZJ-2019-04730},
pages = {1612-1613},
year = {2019},
abstract = {With great interest we read the editorial by Kamson
entitled “Hypometabolic Gliomas on FET-PET—Is There an
Inverted U-Curve for Survival?” in Neuro-Oncology1
referring to our publication regarding the clinical
relevance of photopenic defects on
O-(2-[18F]fluoroethyl)-L-tyrosine (FET) PET in glioma
patients.2 In that paper, we identified within 100 patients
with FET-PET–negative gliomas a subgroup of patients who
even exhibit photopenic defects and had, moreover, an
unfavorable outcome compared with gliomas with indifferent
FET uptake (isometabolic gliomas). From our point of view,
the frequency of photopenic defects is even lower than
$10\%$ (ie, $~5\%).$ In his editorial, the author raised
valuable new thoughts and ideas that are worth discussing.},
cin = {INM-3 / INM-4},
ddc = {610},
cid = {I:(DE-Juel1)INM-3-20090406 / I:(DE-Juel1)INM-4-20090406},
pnm = {572 - (Dys-)function and Plasticity (POF3-572)},
pid = {G:(DE-HGF)POF3-572},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:31504819},
UT = {WOS:000509393300018},
doi = {10.1093/neuonc/noz173},
url = {https://juser.fz-juelich.de/record/865194},
}